INOVIO PHARMACEUTIINOVIO PHARMACEUTIINOVIO PHARMACEUTI

INOVIO PHARMACEUTI

No trades
See on Supercharts

Price target

14.070.000.00%
The 5 analysts offering 1 year price forecasts for GBM have a max estimate of — and a min estimate of —.

Analyst rating

Based on 6 analysts giving stock ratings to GBM in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


GBM EPS for the last quarter is −1.07 CHF despite the estimation of −0.99 CHF. In the next quarter EPS is expected to reach −0.97 CHF. Track more of INOVIO PHARMACEUTI financials and stay on top of what is up with the company.
In the next quarter INOVIO PHARMACEUTI revenue is expected to reach ‪95.62 K‬ CHF. Check out INOVIO PHARMACEUTI revenue and earnings and make informed decisions.
According to analysts, GBM price target is 14.07 CHF with a max estimate of 28.14 CHF and a min estimate of 5.97 CHF. Check if this forecast comes true in a year, meanwhile watch INOVIO PHARMACEUTI stock price chart and keep track of the current situation with GBM news and stock market news.
We've gathered opinions of 6 analysts rating GBM stock in the past 3 months. After counting all points of view, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.